|
Marketing Trumps Safety: the case of Antipsychotics |
|
|
|
|
Thursday, 04 June 2009 |
|
"The story's pretty clear, and pretty embarrassing for the
profession of psychiatry, which has allowed itself to be led by
marketing," says Dr. Robert Rosenheck, Yale.
|
|
Read more...
|
|
|
Antidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer |
|
|
|
|
Sunday, 31 May 2009 |
|
Inexplicably, the FDA has dragged its feet about adding a warning
label to both tamoxefin and the antidepressants, Paxil, Prozac and
Zoloft--despitethe unanimous recommendation of its own advisory panel in 2006.
|
|
Read more...
|
|
|
Japan Revises SSRI Warnings--Hostility, Violence |
|
|
|
|
Friday, 22 May 2009 |
|
The Japanes Ministry of Health, Labor and Welfare has investigated news
reports about antidepressant users "who developed increased feelings of
hostility or anxiety, and have even committed sudden acts of violence
against others."
|
|
Read more...
|
|
|
Title: FDA Approves Antipsychotic With Long History of Failure |
|
|
|
|
Thursday, 07 May 2009 |
The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone :
|
|
Read more...
|
|
|
QuaterWatch: 1,000 + deaths -->Digoxin / Suicide/ Violence -->Chantix |
|
|
|
|
Wednesday, 06 May 2009 |
The latest QuarterWatch report
(May 7, 2009) by the Institute for Safe Medication Practices (ISMP)
found the following disturbing trends during the third Quarter of 2008:
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 10 - 18 of 122 |
Safety Issues